Find your next paid study

Yale UniversityNCT06725277

~$10 – $750

Phase 4

Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

Background: Chronic heavy drinking can cause alcohol use disorder (AUD). AUD changes how the brain works. People with AUD may drink compulsively or feel like …

Alcohol Use Disorder

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT06269627

~$10 – $5,625

RuminationMajor Depressive DisorderAnxiety

Decoding and Modulating Affective Brain States

The research study is being conducted to study brain patterns of negative emotion and develop personalized brain stimulation protocols to disrupt these pattern…

University of PennsylvaniaNCT05437705

Depression DisordersADHDSubstance Abuse+3 more

RCT of Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems

The goal of this study is to test the efficacy of brief video interventions parental internalized stigma and stigma-related outcomes (e.g., treatment intention…

New York State Psychiatric InstituteNCT07594730

~$10 – $7,500

GLAUCOMA 1, OPEN ANGLE, D (Disorder)Glaucoma

Prospective, Single-arm Interventional Study to Determine Effect of Late Ripcord Removal From Glaucoma Drainage Device

This is a research study to find out if removing the ripcord from a glaucoma drainage device more than 3 months after it has been placed has any effect on intr…

Duke UniversityNCT07803536

Phase 2

A Phase 2 Double-blind, Randomised, Placebo-controlled Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of DT-101 in Adults With Major Depressive Disorder Receiving Pharmacological Therapy for Depression

In this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goa…

Major Depressive Disorder (MDD)

Draig Therapeutics LtdNCT07610473

~$10 – $8,750

Phase 3

Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy

The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-ass…

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more

Pierre Fabre MedicamentNCT03394365

~$10 – $7,500

Alcohol Use DisorderAlcohol Related Liver DiseaseLiver Transplant Recipient

Peer Support to Enhance Care for Liver Transplant Recipients Who Had Alcohol-Associated Liver Disease

Liver transplant (LT) recipients with a history of alcohol-related liver disease (ALD) may encounter various psychosocial and medical challenges during post-LT…

Johns Hopkins UniversityNCT07397598

Phase 3

A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (WHO Group 3)

The purpose of this study is to find out if L606 is safe and if it helps people with high blood pressure in the lungs (pulmonary hypertension) caused by inters…

Pulmonary Hypertension Due to Lung Disease (Disorder)

Liquidia Technologies, Inc.NCT07285655

~$10 – $8,750

Tetraplegia/TetraparesisAmyotrophic Lateral Sclerosis (ALS)Muscular Disorders, Atrophic+6 more

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

The goal of this clinical trial is to evaluate the safety and preliminary efficacy of an implantable device that records and stimulates different areas of the …

Johns Hopkins UniversityNCT07521930

Phase 2

A Target Engagement Study of Pimavanserin for Behavioral Inflexibility With Open Label Trial for Rigid Rigid-compulsive Behavior in Adolescents and Adults With Autism

This Phase 2 study examines the safety, tolerability, and preliminary efficacy of pimavanserin in individuals with Autism Spectrum Disorder. Male or female par…

Autism Spectrum Disorder

New York State Psychiatric InstituteNCT05999240

~$10 – $7,500

Phase 2

An Open-label Study Evaluating DT402 in Adults With Autism Spectrum Disorder

A Phase 2A Trial of DT402 Open-Label Study in Adults with Autism Spectrum Disorder

Autism Spectrum DisorderASD